Hamid, Kardo .

HRN: 21-35-28  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2022
CEFTRIAXONE 1G (VIAL)
12/23/2022
12/30/2022
IV
670 Mg
Q24
PCAP-C
Waiting Final Action 
12/28/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/28/2022
01/03/2023
IVT
670mg
Q8
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: